21-26 April – online
27-28 April – offline
Live broadcast from Moscow
New Reality – New Strategies Russian Pharmaceutical Market Leaders’ Forum
Winners will be determined in 16 nominations Read more Russian Pharma Inspiration Awards 8 days of business communication Meet and develop business contacts online and offline! Read more Networking

SPEAKERS

Confirmed Speakers

Sergey Arabadzhyan

Elena Astapenko

Dmitry Reykhart

COMPANIES

Top managers of leading international and Russian pharmaceutical companies participate in Advantix Pharma conferences

PARTICIPATION

Why should you take part in the Forum?

1 – Content

Only the leading industry players, regulators, representatives of healthcare institutions and patient organisations will speak at the Forum of Leaders of the Russian Pharmaceutical Market. In 25+ sessions over 6 days, industry leaders will discuss the hottest topics. Strategies, development trends of the state and commercial segments, sales, marketing, regulatory and medical issues – you will not find such comprehensive set of questions in other events programs!

2 – Knowing the audience

Advantix Pharma builds events program according to the needs of its target audience, our understanding of the industry is based on the extensive market research. The multi-day and multi-threaded program is designed in accordance with the interests of professionals in certain positions: top managers, directors of strategy, marketing, sales, regulatory and medical affairs.

3 – Networking

The hybrid event format provides enhanced opportunities for business communication. We are delighted to see the return of events to offline format. Personal communications on the side-lines of event, over a cup of coffee and a glass of champagne, will always be an effective tool for developing existing and establishing new business contacts. At the same time, the online format provides an opportunity to communicate with the main stakeholders of the industry, regardless of your and their location. Online networking is a great way to meet people and identify common interests, which can be further developed during personal meetings in an offline format.

EVENT ORGANISERS

Welcome forum participants

The hybrid format makes it possible to unite the leading players of the Russian pharmaceutical market located both in Moscow and in other regions of the country and abroad. Meet and develop business contacts online and offline!

Natalia Baeva Advantix Pharma

Dear colleagues,

 

We would like to invite you to join the Russian Pharmaceutical Market Leaders’ Forum organised by Advantix Pharma. The forum will be held in a hybrid format – online only from the 21st until the 26th April and offline in Moscow on 27th and 28th of April with online broadcast.

A leader is someone who knows how to build strategies that allow companies to achieve market advantage, in a highly competitive environment. A leader can identify problems, build effective communications with various groups of stakeholders, and offer solutions to problems of varying complexity.

A leader is someone who knows how to take risks and responsibility to find innovative solutions for various patient groups.

The Russian Pharmaceutical Market Leaders’ Forum will bring together 400+ representatives of regulatory authorities, leading Russian and international pharmaceutical producers, distributors, pharmacy chains, healthcare institutions and patient organisations.

How have expectations of regulators, healthcare community and patient organisations to pharmaceutical companies changed in the face of a global pandemic? What strategies will be most effective in the state and commercial segments of the pharmaceutical market? How have the approaches of pharmaceutical companies to the introduction of digital tools changed? These and many other questions will be discussed at the Advantix Pharma forum.

We look forward to welcoming you at the Russian Pharmaceutical Market Leaders’ Forum in April!

With warmest regards,

Natalia Baeva
Director of pharmaceutical projects
Advantix Pharma

PROGRAMME

Key Themes

Trends in the development of healthcare systems and pharmaceutical companies in the new reality

International and Russian pharmaceutical companies’ strategies on the Russian market

Trends in the development of the public procurement segment and the commercial segment in Russia

Innovation contracts in the pharmaceutical industry

Implementation of state programs in the field of oncology and cardiology

Drug provision for patients with orphan diseases

List of vital and essential drugs and pricing of medicines

The withdrawal of drugs from the Russian market by international players: is there a replacement available?

Drug labelling

Patient-centred approach in healthcare

Access to innovative drugs for the Russian market: challenges and solutions

Strategies for bringing drugs to the market in a new reality

Protection of intellectual property rights in the Russian pharmaceutical market

Compulsory licencing practice

Early access of pharmaceutical drugs to the market

Registration of medicinal products according to the EAEU rules: first results after full transition in Russia

Vaccination against COVID-19: vaccine production, logistics, vaccine promotion, pricing

Localisation of drug production

Providing pharmaceutical companies with substances. Development of substances production in Russia

Export of Russian-made pharmaceuticals

Digital transformation of the healthcare system and pharmaceutical companies

Cybersecurity in pharmaceutical industry

Pharma 4.0 - the latest production technologies in the pharmaceutical industry

Mergers and acquisitions in the pharmaceutical industry

Trends in the development of the wholesale and retail segment of the pharmaceutical market in Russia

Development of online sales of medicines in Russia

Promotion of medicines in the new reality

Work with doctors in the new reality

Medical representatives of the future

Marketing mix

Digital tools in promoting medicines

KPIs in pharmaceutical marketing

OFFLINE

27-28 April 2021

Interactive discussions

Round tables

Presentations

Exhibition

Interactive surveys

One-to-one meetings

Cocktail reception

Networking coffee breaks

Digital scribing

Awards ceremony

ONLINE

21-28 April 2021

Interactive discussions

Round tables

Presentations

Virtual exhibition

Interactive surveys

One-to-one meetings

Digital scribing

Awards ceremony

Virtual yoga

Prize draws

Private chats

Virtual meeting rooms

SPONSORSHIP

Sponsorship Opportunities

Hybrid events provide enhanced opportunities for companies to promote their brands, expertise, products, and services. We can develop an individual package based on your requirements and preferences. You can choose to become a partner for online or offline only format; or combine both options as a complex solution.

Olga Granovskaya Advantix Pharma
400
participants
120
speakers
25
sessions
8
days of business communication
400+

400+ participants from regulatory bodies, leading international and Russian pharmaceutical manufacturers, distributors, pharmacy chains and companies providing services for the pharmaceutical sector.

120+

120+ speakers from regulators, leading pharmaceutical manufacturing companies, distributors and pharmacy chains.

25+

The forum will feature 25+ sessions on regulation, strategy, sales, marketing and manufacturing.

8

The event programme includes 8 days of content and business communication, 2 days will be held in a hybrid format: offline in Moscow + online.

PARTNERS

Pharmaceutical Partner

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population. At the same time, the Group aims to increase its earning power and create value through innovation and growth. Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2019, the Group employed around 104,000 people and had sales of 43.5 billion euros. Capital expenditures amounted to 2.9 billion euros, R&D expenses to 5.3 billion euros.

For more information, go to: bayer.com.

INFORMATION PARTNERS

Supporting associations and information partners

DELEGATES

Participation Cost

$ 1200

  • Before 27 February 2021

$ 1300

  • Before 27 March 2021

$ 1400

  • After 27 March 2021